Breath Therapeutics
Advanced inhalation technologies
Breath Therapeutics has raised €44M across 1 funding round from 3 investors, most recently a Series A round in Mar 2017. Based in Munich, Germany; active in Healthtech. Data as of 4 Nov 2026.
Munich, Germanywww.pari.com/de-en/home ↗
Total raised
€44M
€43,500,000
Funding rounds
1
Investors
3
distinct backers
Active since
2017-03
latest 2017-03
Funding by year
EUR raised per yearBreath Therapeutics — funding by year — interactive chart.
Data table
| Breath Therapeutics — funding by year | |
|---|---|
| 2017 | €44M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-03-01 | Series A | €44M | Gilde Healthcare,GIMV,Sofinnova Partners | View deal → |
Investors
3Related news
Similar companies
same sector, similar size- Market Logic€45MGermany · Healthtech
- Centogene€25MGermany · Healthtech
- Rigontec€28MGermany · Healthtech
- Abalos Therapeutics€43MGermany · Healthtech
- Brillen.de€45MGermany · Healthtech
- Allecra Therapeutics€37MGermany · Healthtech
Global coverage: FundingData